You would expect that to be positive news for IMU rather than VLA, with Axel Hoos being a director of IMU as well as his role at GSK. IMUs market cap is only a tenth of VLA's.
http://www.fiercebiotech.com/story/.../2015-06-18?utm_medium=nl&utm_source=internal
- Forums
- ASX - By Stock
- Possible Buyer in the Wind
You would expect that to be positive news for IMU rather than...
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)